Cargando…

High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148062/
https://www.ncbi.nlm.nih.gov/pubmed/27813532
http://dx.doi.org/10.1038/bcj.2016.99
_version_ 1782473791771770880
collection PubMed
description
format Online
Article
Text
id pubmed-5148062
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51480622016-12-23 High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression Blood Cancer J Letter to the Editor Nature Publishing Group 2016-11 2016-11-04 /pmc/articles/PMC5148062/ /pubmed/27813532 http://dx.doi.org/10.1038/bcj.2016.99 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
title High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
title_full High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
title_fullStr High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
title_full_unstemmed High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
title_short High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression
title_sort high-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large b-cell lymphoma patients with myc/bcl2 co-expression
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5148062/
https://www.ncbi.nlm.nih.gov/pubmed/27813532
http://dx.doi.org/10.1038/bcj.2016.99